Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
WHO
Pharma
Innoviva scores FDA nod for gonorrhea drug one day after GSK
The FDA has signed off on Innoviva’s Nuzolvence as a treatment for gonorrhea one day after it granted a similar nod to GSK’s antibiotic Blujepa.
Kevin Dunleavy
Dec 12, 2025 3:31pm
Orchid granted license to produce antibiotic to meet global need
Sep 12, 2023 9:55am
More COVID vaccine market uncertainty on tap for pharma: analyst
Apr 10, 2023 11:53am
GSK's rotavirus shot runs short due to manufacturing issues
Aug 11, 2022 4:00pm
Bavarian Nordic wins monkeypox vaccine approval in Europe
Jul 25, 2022 11:45am
COVID tracker: FDA breathalyzer nod, Pfizer, Moderna, and more
Apr 13, 2022 10:55am
